ADC Therapeutics SA 8-K

What Happened
ADC Therapeutics SA (ADCT) filed a Current Report on Form 8‑K on June 24, 2026 reporting a Regulation FD disclosure (Item 7.01) and certain other events (Item 8.01). The filing includes a press release dated June 24, 2026 as Exhibit 99.1 and an Inline XBRL cover page (Exhibit 104). The filing text indicates the press release and related information are incorporated by reference into the report.

Key Details

• Filing date: June 24, 2026 (Current Report on Form 8‑K).
• Reported items: Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events).
• Exhibits: 99.1 — Press release dated June 24, 2026; 104 — Cover Page Interactive Data File (Inline XBRL).
• The 8‑K does not disclose any Item 2.02 (earnings/financial results), Item 5.02 (executive changes), Item 1.01 (merger/acquisition) or Item 1.03 (bankruptcy).

Why It Matters
A Regulation FD disclosure filing means ADC Therapeutics publicly disclosed information to ensure fair access to material information. Investors should review the attached press release (Exhibit 99.1) to see the specific news or data the company released. Because this 8‑K does not contain earnings, leadership changes, or transaction notices, the next steps for investors are to read the press release and monitor subsequent filings for any material financial or corporate developments.